(PharmaNewsWire.Com, April 07, 2017 ) As per the syndicated report published by Market Data Forecast Europe Contraceptives which is estimated to be USD 5.59 billion in 2016 is poised to reach USD 7.66 billion by 2021, at a CAGR of 6.50% from 2016 to 2021.
It can attribute to the factors such as increasing development of effective female contraceptive devices and drugs, increasing initiatives from government and NGO to promote contraceptives, advancement in technologies are drivers of Europe Contraceptives Market. Restraints the growth of the market are the side effects associated with the use of contraceptive devices and drugs, rising prevalence of infertility. The European contraceptives market enjoys a high degree of product penetration especially, in segments such as intrauterine devices (IUD) and subdermal implants.
Male and female condoms, sponges, IUDs, vaginal implants, subdermal implants, and diaphragms are important devices and accounted for the largest share of the market in terms of revenue. This is attributed to the efficiency of condoms to inhibit the infections and growing awareness about STD (Sexually transmitted disease), including HIV. In a recent study, subdermal implants have been recognized to have an immense potential to meet the need of women for family planning.
Europe Contraceptives Market is segmented based on Drug type and Medical Devices as mentioned below for attaining a more granular perspective of the market. In the report each sub segment is provided with Market Size Estimations and Y-o-Y Forecasts.
Based on Drug type: Contraceptive pills Topical contraceptives Contraceptive injectable Others (contraceptive gels, jellies and creams) Based on Medical Devices: Male contraceptive devices Female contraceptive devices Female condoms Intrauterine devices Contraceptive sponges Contraceptive diaphragms Contraceptive patches Subdermal contraceptive implants Non-surgical permanent contraceptive devices
The Europe market is analyzed under various regions namely U.K, Germany, France, Italy, and Spain.
The key players in Europe Contraceptives Market are Bayer HealthCare AG, Mayer Laboratories, Inc., Teva Pharmaceutical Industries Limited, Medicines360, Church & Dwight, Co., Inc., Actavis, Inc., CooperSurgical, Inc., Medisafe Distribution Inc, Pace Pharmaceuticals Inc., Merck & Co., Inc., Reckitt Benckiser plc, and Pfizer, Inc.
Technological advancements in intrauterine contraceptive devices are expected to create new opportunities for new players in the global intrauterine contraceptive device market in the years to come. Rising number of product innovations and increasing number of acquisitions and mergers are some of the recent trends witnessed in the global intrauterine contraceptive device market. The Contraceptives Market study offers the following deliverables: Regional and country-level analysis that provides an innate perspective of European region and the aforementioned countries Meticulously identifying the key areas of market growth by providing market size forecasts and y-o-y estimations at a Segment-level analysis Explanations of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors that affect the European market presented in the form of PESTLE and Porters Five Forces Analyses Company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview of the key market players operating in the region Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook - Investment opportunities to provide both individuals and organizations a strong financial foothold in the market Checkout other related studies in the Medical Devices Segment:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
